Alkermes Plc (ALKS)
- Exchange
- NASDAQ
- Symbol
- ALKS
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland.
- Country
- USA
Stock price
At close: December 3, 2024
-
Open29.40
-
High29.55
-
Low29.06
-
Close29.48
-
Volume1,038,750
Financial ratios
Sep 30, 2024
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
3.60
Receivables turnover
4.06
Payables turnover
18.59
Working capital turnover
1.34
Days of inventory on hand (DOH)
101.30
Days of sales outstanding (DSO)
89.80
Number of days of payables
19.63
Fixed asset turnover
6.62
Total asset turnover
0.69
Current ratio
3.45
Quick ratio
2.81
Cash ratio
2.00
Cash conversion cycle
171.46
Debt-to-assets ratio
0.13
Debt-to-capital ratio
0.18
Debt-to-equity ratio
0.22
Financial leverage ratio
1.67
Interest coverage
12.50
Gross profit margin
29.02%
Operating profit margin
29.25%
Pretax margin
19.22%
Net profit margin
22.33%
Operating return on assets (Operating ROA)
20.25%
Return on assets (ROA)
15.47%
Return on total capital
19.00%
Return on equity (ROE)
25.80%